CARRI', MARIA TERESA
 Distribuzione geografica
Continente #
NA - Nord America 44.876
EU - Europa 3.871
AS - Asia 3.412
SA - Sud America 582
Continente sconosciuto - Info sul continente non disponibili 399
AF - Africa 42
OC - Oceania 12
Totale 53.194
Nazione #
US - Stati Uniti d'America 44.680
SG - Singapore 1.547
DE - Germania 703
CN - Cina 680
UA - Ucraina 604
BR - Brasile 469
RU - Federazione Russa 413
PL - Polonia 405
FR - Francia 382
HK - Hong Kong 353
IE - Irlanda 323
VN - Vietnam 317
IT - Italia 315
GB - Regno Unito 217
FI - Finlandia 173
SE - Svezia 169
KR - Corea 123
CA - Canada 119
JP - Giappone 95
BD - Bangladesh 86
IN - India 55
NL - Olanda 42
AR - Argentina 29
ID - Indonesia 28
MX - Messico 25
GR - Grecia 22
EC - Ecuador 21
ES - Italia 19
VE - Venezuela 19
BE - Belgio 17
CO - Colombia 16
IQ - Iraq 16
ZA - Sudafrica 16
AT - Austria 15
TR - Turchia 15
CL - Cile 12
CR - Costa Rica 12
IL - Israele 12
CZ - Repubblica Ceca 11
EU - Europa 11
MY - Malesia 11
PH - Filippine 11
PK - Pakistan 11
UZ - Uzbekistan 11
AU - Australia 10
JM - Giamaica 9
SA - Arabia Saudita 9
NI - Nicaragua 8
MA - Marocco 7
PY - Paraguay 7
RO - Romania 7
CH - Svizzera 6
DK - Danimarca 6
HN - Honduras 5
EG - Egitto 4
KG - Kirghizistan 4
LT - Lituania 4
SV - El Salvador 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
GT - Guatemala 3
IR - Iran 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GH - Ghana 1
GY - Guiana 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
MZ - Mozambico 1
Totale 52.796
Città #
Woodbridge 12.914
Wilmington 10.782
Houston 10.290
Fairfield 1.315
Ashburn 1.125
Ann Arbor 1.004
Singapore 885
Jacksonville 547
Seattle 505
Chandler 484
San Jose 464
Cambridge 446
Kraków 389
Hong Kong 345
Dublin 314
Dearborn 292
Medford 258
Beijing 257
The Dalles 236
Council Bluffs 177
Santa Clara 164
New York 163
Los Angeles 124
Lawrence 122
Ho Chi Minh City 100
Mülheim 94
Buffalo 84
Rome 80
Tokyo 80
Hanoi 77
San Diego 66
Menlo Park 55
Helsinki 53
Dallas 50
Norwalk 47
Moscow 46
Toronto 42
Milan 41
Detroit 40
Falls Church 38
Phoenix 38
Mountain View 37
Munich 37
Zhengzhou 36
Lauterbourg 35
Carrboro 34
São Paulo 34
Boardman 33
London 32
University Park 31
Chicago 30
Montreal 30
Reading 29
North Bergen 27
Guangzhou 26
Atlanta 24
Redwood City 23
Saint Petersburg 22
Jakarta 21
Denver 20
Verona 20
Amsterdam 19
Brooklyn 19
Thessaloniki 18
Brussels 17
Frankfurt am Main 16
Nanjing 16
Nürnberg 16
Haiphong 15
Hefei 15
Orem 15
Rio de Janeiro 15
Saint Augustine 15
Columbus 14
Kunming 14
San Francisco 14
Shanghai 14
Da Nang 13
Nuremberg 13
Warsaw 13
Brasília 11
Chennai 11
Jinan 11
Lansdale 11
San Mateo 11
Kaiserslautern 10
Kyiv 10
Manchester 10
North Charleston 10
Philadelphia 10
San José 10
Stockholm 10
Brno 9
Johannesburg 9
Ankara 8
Campinas 8
Hounslow 8
Naples 8
Poplar 8
Baghdad 7
Totale 45.695
Nome #
S -Nitrosoglutathione Reductase Plays Opposite Roles in SH-SY5Y Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis 555
Mutation of Lys-120 and Lys-134 drastically reduces the catalytic rate of Cu,Zn superoxide dismutase 535
Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications 525
Three-dimensional structure of Xenopus laevis Cu,Zn superoxide dismutase b determined by X-ray crystallography at 1.5 A resolution 521
Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis 521
Differential role of superoxide and glutathione in S-nitrosoglutathione-mediated apoptosis: a rationale for mild forms of familial amyotrophic lateral sclerosis associated with less active Cu,Zn superoxide dismutase mutants 518
Copper depletion increases the mitochondrial-associated SOD1 in neuronal cells 514
Superoxide dismutase 1 modulates expression of transferrin receptor 509
Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals 509
2-DE and MALDI-TOF-MS for a comparative analysis of proteins expressed in different cellular models of amyotrophic lateral sclerosis 508
Activation and induction by copper of Cu/Zn superoxide dismutase in Saccharomyces cerevisiae. Presence of an inactive proenzyme in anaerobic yeast 506
A study of the dual role of copper in superoxide dismutase as antioxidant and pro-oxidant in cellular models of amyotrophic lateral sclerosis 506
Inactivation of cytochrome c oxidase by mutant SOD1s in mouse motoneuronal NSC-34 cells is independent from copper availability but is because of nitric oxide 501
Apoptotic mechanisms in mutant LRRK2-mediated cell death 497
Structural insights into the multi-determinant aggregation of TDP-43 in motor neuron-like cells 497
Developmental expression of Cu,Zn superoxide dismutase in Xenopus. Constant level of the enzyme in oogenesis and embryogenesis 494
Regulation of CU, ZNSOD by metals in S-Cereivisiae and Zea-Mays 493
Dynamic NAD(P)H post-synaptic autofluorescence signals for the assessment of mitochondrial function in a neurodegenerative disease: monitoring the primary motor cortex of G93A mice, an amyotrophic lateral sclerosis model 491
Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials 491
Effect of Lys->Arg mutation on the thermal stability of Cu,Zn superoxide dismutase: Influence on the monomer-dimer equilibrium 490
The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis. 490
Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice 488
Apoptosome inactivation rescues proneural and neural cells from neurodegeneration 486
Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress 482
Xenopus laevis Cu,Zn superoxide dismutase B cDNA sequence 480
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase 479
An electron microscope study of chromosomal DNA replication in different eukaryotic systems 478
Copper-dependent oxidative stress and neurodegeneration 477
ALS: focus on purinergic signalling 476
Interaction of cisplatin with human superoxide dismutase 475
Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS 475
Xenopus laevis U1 snRNA genes: characterisation of transcriptionally active genes reveals major and minor repeated gene families 474
Voltage-activated sodium currents in a cell line expressing a Cu,Zn superoxide dismutase typical of familial ALS 474
Role of zinc-coordination and of the glutathione redox couple in the redox susceptibility of human transcription factor Sp1 474
Temperature-dependent protein folding in vivo--lower growth temperature increases yield of two genetic variants of Xenopus laevis Cu,Zn superoxide dismutase in Escherichia coli 474
Metal uptake of recombinant cambialistic superoxide dismutase from Propionitbacterium shermanii is affected by growth conditions of host Escherichia coli cells 471
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 471
Purification and characterization of Ag,Zn-superoxide dismutase from Saccharomyces cerevisiae exposed to silver 471
Impaired copper binding by the H46R mutant of human Cu,Zn superoxide dismutase, involved in amyotrophic lateral sclerosis 470
The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis 468
Amyotrophic Lateral Sclerosis: New Insights into Underlying Molecular Mechanisms and Opportunities for Therapeutic Intervention 468
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 467
The relationship between chromosomal origins of replication and the nuclear matrix during the cell cycle 466
Cu,Zn-superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells 463
Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways 463
Oligomerization of mutant SOD1 in mitochondria of motoneuronal cells drives mitochondrial damage and cell toxicity 462
The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis 462
Bcl2-A1 interacts with pro-caspase-3: Implications for amyotrophic lateral sclerosis. 459
Minocycline for patients with ALS. 455
The intriguing case of motor neuron disease: ALS and SMA come closer 454
Evidence for co-regulation of Cu,Zn superoxide dismutase and metallothionein gene expression in yeast through transcriptional control by copper via the ACE 1 factor 453
Differential role of superoxide and glutathione in S-nitrosoglutathione-mediated apoptosis: A rationale for mild forms of familial amyotrophic lateral sclerosis associated with less active Cu,Zn superoxide dismutase mutants 452
Amyotrophic lateral sclerosis: mechanisms and countermeasures 451
Cell death in amyotrophic lateral sclerosis: interplay between neuronal and glial cells 451
Chromosome length and DNA loop size during early embryonic development of Xenopus laevis 450
Lessons from models of SOD1-linked familial ALS 449
Continuous monitoring of ascorbate transport through neuroblastoma cells with a ruthenium oxide hexacyanoferrate modified microelectrode 449
Glutaredoxin 1 is a major player in copper metabolism in neuroblastoma cells 449
Mitochondrial damage modulates alternative splicing in neuronal cells: implications for neurodegeneration 448
LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization 448
Pathways to mitochondrial dysfunction in ALS pathogenesis 447
Oxidative stress and mitochondrial damage: Importance in non-SOD1 ALS 446
Apoptosome-deficient cells lose cytochrome c through proteasomal degradation but survive by autophagy-dependent glycolysis 445
Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease 445
Neuronal RNA-binding proteins in health and disease 444
Pur-alpha functionally interacts with FUS carrying ALS-associated mutations 444
Expression of a Cu, Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of neuroblastoma cells to infectious injury 443
Activity of protein phosphatase calcineurin is decreased in sporadic and familial amyotrophic lateral sclerosispatients 443
Oxidative inactivation of calcineurin by Cu,Zn superoxide dismutase G93A, a mutant typical of familial amyotrophic lateral sclerosis 442
Primary structure from amino acid and cDNA sequences of two Cu,Zn superoxide dismutase variants from Xenopus laevis 442
Altered gene expression, mitochondrial damage and oxidative stress: converging routes in motor neuron degeneration 442
Cystatin B and SOD1: protein–protein interaction and possible relation to neurodegeneration 441
SIRT3 and mitochondrial metabolism in neurodegenerative diseases 441
Which TDP-43 aggregates are toxic in ALS? 439
Mitochondria and ALS: Implications from novel genes and pathways 437
Glutaredoxin 2 prevents aggregation of mutant SOD1 in mitochondria and abolishes its toxicity 434
Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosis-superoxide dismutase 434
A relationship between replicon size and supercoiled loop domains in the eukaryotic genome 431
The role of metals and their effect on oxidative stress in amyotrophic lateral sclerosis 431
Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis 430
Apaf1 mediates apoptosis and mitochondrial damage induced by mutant human SOD1s typical of familial amyotrophic lateral sclerosis 428
Increase of Cu,Zn-superoxide dismutase activity during differentiation of human K562 cells involves activation by copper of a constantly expressed copper-deficient protein 425
Cysteine modifications in the pathogenesis of ALS 422
SOD1 and mitochondria in ALS: a dangerous liaison. 421
Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells 416
The Cu,Zn superoxide dismutase isoenzymes of Xenopus laevis: purification, identification of a heterodimer and differential heat sensitivity 414
Copper-dependent oxidative stress, alteration of signal transduction and neurodegeneration in amyotrophic lateral sclerosis 414
Increased SOD1 association with chromatin, DNA damage, p53 activation, and apoptosis in a cellular model of SOD1-linked ALS 413
Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives 411
Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis 410
Crystal structure of the cyanide-inhibited Xenopus laevis Cu,Zn superoxide dismutase at 98 K 409
Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases 408
Mitochondrial dysfunction in ALS 407
Inflammatory cytokines increase mitochondrial damage in motoneuronal cells expressing mutant SOD1 406
Mutant SOD1 and mitochondrial damage alter expression and splicing of genes controlling neuritogenesis in models of neurodegeneration 401
Mislocalised FUS mutants stall spliceosomal snRNPs in the cytoplasm. 399
Mitochondrial redox signalling by p66Shc mediates ALS-like disease through Rac1 inactivation 398
Apoptosome-deficient cells lose cytochrome c through proteasomal degradation but survive by autophagy-dependent glycolysis 397
Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis 395
Continuous monitoring of ascorbate transport through neuroblastoma cells with a ruthenium oxide hexacyanoferrate modified microelectrode 394
Totale 45.822
Categoria #
all - tutte 110.717
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.717


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022996 0 0 0 58 34 115 70 51 100 105 78 385
2022/20231.376 150 104 25 212 101 315 115 61 130 6 128 29
2023/2024347 61 6 17 8 36 111 10 20 4 2 1 71
2024/20252.314 92 533 250 128 52 227 157 165 201 172 192 145
2025/20264.193 299 237 508 327 325 123 448 538 439 532 221 196
2026/20271.907 268 236 1.035 368 0 0 0 0 0 0 0 0
Totale 53.194